Loading organizations...
§ Private Profile · South San Francisco, CA, USA
MiNDERA Corporation is a technology company.
Mindera Health develops Dermal Intelligence™, a precision medicine platform for dermatological conditions. Its core product, Mind.Px™, employs a patented, minimally invasive device to collect genetic biomarkers (RNA transcripts) from skin. This data undergoes analysis via machine learning and next-generation sequencing, predicting a patient's response to biologic treatments for psoriasis, guiding personalized therapy and minimizing trial-and-error.
Founded in 2013 as MiNDERA Corporation, with Tahir Mahmood as a co-founder, the company emerged from inefficiencies in dermatologic treatment. Costly, ineffective biologic drug trials were common, prompting founders to apply molecular biology and computational analysis. They provided non-invasive, actionable insights into patient biology to optimize treatment.
Mindera Health benefits patients, healthcare providers, and payers by improving outcomes and reducing costs. It offers physicians data-driven confidence for treatment selection, leading to more effective patient therapies. Its long-term vision is to pioneer molecular skin analytics, extending its technology to broader medical indications, continually advancing health through precision medicine.
MiNDERA Corporation has raised $26.6M across 2 funding rounds.
MiNDERA Corporation has raised $26.6M in total across 2 funding rounds.
MiNDERA Corporation has raised $26.6M in total across 2 funding rounds.
MiNDERA Corporation's investors include Mountain Group Partners.
MiNDERA Corporation has raised $26.6M across 2 funding rounds. Most recently, it raised $14.0M Other Equity in August 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2024 | $14M Venture Round | Mountain Group Partners | — | Announced |
| May 12, 2021 | $12.6M Series A | — | — | Announced |
MiNDERA Corporation refers to entities matching this name, but search results highlight two primary technology companies: Mindera (mindera.com), a global AI-enabled software engineering and consulting firm, and the former Mindera Corporation (now Mindera Health), a precision medicine platform developer. Mindera, founded in 2014 and headquartered in Ílhavo, Portugal, builds custom software solutions including web/mobile apps, AI, data management, cloud services, and agile consulting, serving industries like fintech, public sector, retail, gaming, travel, and transportation with over 1,100 employees across nine locations from the UK to Australia.[1][3][4][5] It delivers scalable, secure systems via full-stack teams, team augmentation, and tech stacks like React, Java, Swift, Kotlin, AWS, and Kubernetes, optimizing efficiency and customer journeys.[1][5] The rebranded Mindera Health (previously MiNDERA Corporation), based in San Diego, CA, develops the Mind.Px™ platform using dermal biomarker patches, next-generation sequencing, and machine learning for personalized psoriasis treatment, targeting dermatology's $25B market to predict biologic drug responses and cut costs.[2]
Mindera's growth momentum stems from its decentralized model and client-centric delivery, working with global brands on complex problems, while Mindera Health focuses on CLIA/CAP-certified labs advancing skin analytics for better outcomes in an 8M-patient psoriasis space.[1][2][4]
Mindera originated in 2014 in Ílhavo, Portugal, as a software engineering firm disrupting traditional hierarchies with a self-organized, decentralized structure inspired by principles like RenDanHeYi, emphasizing employee autonomy and ownership.[3][4] It evolved from core web/mobile development to a full-service provider incorporating AI, data, product design, QA, security, and business consulting, expanding globally to over 1,000 employees across Portugal, the UK, US, and beyond.[1][4][5] Key early focus was on robust, scalable apps for sectors like retail and gaming, building long-term client relationships through empowered teams.[3][4]
Separately, MiNDERA Corporation (San Diego, pre-2021 rebrand to Mindera Health) emerged as a medtech innovator developing Mind.Px™, the first personalized medicine tool for psoriasis via genetic biomarkers and ML; it sharpened its focus via the 2021 name change to reflect its data-driven dermatology platform.[2] No specific founders are detailed in results, but pivotal moments include ISO 13485 certification and addressing 48% biologic failure rates.[2]
These set Mindera apart from competitors like HeaderLabs or RailsCarma by prioritizing people-first autonomy over rigid models.[3][4]
Mindera rides the wave of AI democratization and decentralized work, timing perfectly with post-pandemic remote scaling and demand for agile, AI-infused custom software amid digital transformation.[1][4] Market forces like exploding fintech/public sector digitization and need for secure, scalable apps favor its global footprint and expertise, influencing the ecosystem by proving self-organization boosts delivery speed and satisfaction in a fragmented outsourcing market.[4][5] It empowers startups/corporates via MVPs and augmentation, echoing trends in no-hierarchy firms.
Mindera Health taps personalized medicine's boom, leveraging ML/genomics amid rising biologics use and payer pressure to cut $25B dermatology waste; its biomarkers address AAD calls for predictive tools, shaping skin analytics and value-based care.[2]
Mindera will likely expand AI labs and decentralized teams to capture more enterprise AI projects, shaped by generative AI trends and hybrid work, evolving as a go-to for humanistic digital solutions amid talent wars.[1][4] Mindera Health eyes broader dermatology/precision med applications, riding NGS cost drops and outcome-focused healthcare shifts, potentially influencing payer adoption.
Tying to the tech company roots, both exemplify how AI-software fusion drives practical impact—from code to cures—in a precision era.